Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Arvinas Inc
(NQ:
ARVN
)
32.68
+0.57 (+1.78%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Arvinas Inc
< Previous
1
2
3
4
5
6
Next >
Abercrombie & Fitch To Rally 21%? Plus This Analyst Predicts $237 For Autodesk
November 23, 2022
Telsey Advisory Group raised the price target on Abercrombie & Fitch Co. (NYSE: ANF) from $25 to $27. Abercrombie & Fitch shares fell 1.2% to $22.34 in pre-market trading.
Via
Benzinga
Arvinas's ARV-471 Achieves Clinical Benefit Rate Of 38% In Breast Cancer Setting
November 22, 2022
Via
Benzinga
Arvinas Announces ARV-471 Achieves a Clinical Benefit Rate of 38% in Evaluable Patients and Continues to Show a Favorable Tolerability Profile in its Phase 2 Expansion Trial (VERITAC)
November 22, 2022
From
Arvinas Inc.
Via
GlobeNewswire
Carvana, Crocs And Other Big Losers From Monday
November 22, 2022
U.S. stocks closed lower on Monday, with the Nasdaq dropping more than 100 points. Here is the list of some big stocks recording losses in the previous session.
Via
Benzinga
Where Arvinas Stands With Analysts
September 09, 2022
Within the last quarter, Arvinas (NASDAQ:ARVN) has observed the following analyst ratings:
Via
Benzinga
Expert Ratings for Arvinas
September 09, 2022
Within the last quarter, Arvinas (NASDAQ:ARVN) has observed the following analyst ratings:
Via
Benzinga
Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday
November 22, 2022
Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash.
Via
Benzinga
Why TuanChe Shares Are Trading Lower By 76%? Here Are 48 Stocks Moving In Monday's Mid-Day Session
November 21, 2022
Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares jumped 104% to $35.50 after Merck announced it would acquire the company for $36 per share in cash.
Via
Benzinga
Arvinas Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 08, 2022
From
Arvinas Inc.
Via
GlobeNewswire
Arvinas to Present at Upcoming Conferences
November 01, 2022
From
Arvinas Inc.
Via
GlobeNewswire
Wingstop, Harley-Davidson, Rollins And Some Other Big Stocks Moving Higher On Wednesday
October 26, 2022
U.S. stocks traded mixed, with the Dow Jones gaining more than 200 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Recap: Arvinas Q2 Earnings
August 04, 2022
Arvinas (NASDAQ:ARVN) reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
7 Analysts Have This to Say About Arvinas
June 21, 2022
Arvinas (NASDAQ:ARVN) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Analyst Ratings for Arvinas
May 20, 2022
Arvinas (NASDAQ:ARVN) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Arvinas Announces Winner of the 2022 Arvinas Early Career Researcher Award
October 27, 2022
Katherine Donovan, Ph.D. of the Dana-Farber Cancer Institute has been awarded a $25,000 monetary prize recognizing her innovation in the field of targeted protein degradation
From
Arvinas Inc.
Via
GlobeNewswire
Arvinas Appoints Paul McInulty as Senior Vice President, Regulatory Affairs
October 03, 2022
From
Arvinas Inc.
Via
GlobeNewswire
Why New Oriental Education Shares Jumped Over 28%; Here Are 68 Biggest Movers From Yesterday
October 27, 2022
Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares climbed 180.2% to close at $4.82 on Wednesday after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the...
Via
Benzinga
Arvinas Gives Back to Local Greater New Haven Community
September 30, 2022
From
Arvinas Inc.
Via
GlobeNewswire
Why Seagate Shares Are Trading Lower By More Than 7%? Here Are 49 Stocks Moving In Wednesday's Mid-Day Session
October 26, 2022
Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares surged 59.3% to $2.7417 after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the 29th Annual Prostate...
Via
Benzinga
Arvinas's Return on Invested Capital Insights
August 22, 2022
According to Benzinga Pro data, Arvinas (NASDAQ:ARVN) reported Q2 sales of $31.30 million. Earnings fell to a loss of $70.00 million, resulting in a 10.41% decrease from last quarter.
Via
Benzinga
Sanofi's Breast Cancer Drug Fallout 'Creates Buying Opportunity' For This Stock
August 18, 2022
According to Oppenheimer analyst, the fallout of Sanofi SA's (NASDAQ: SNY) amcenestrant creates a buying opportunity for Arvinas Inc (NASDAQ: ARVN)
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
September 09, 2022
Upgrades
Via
Benzinga
Sanofi, Children's Place And Some Other Big Stocks Moving Lower On Wednesday
August 17, 2022
Embark Technology, Inc. (NASDAQ: EMBK) fell 25.1% to $12.40. Embark Technology reported the completion of reverse stock split.
Via
Benzinga
This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday
August 18, 2022
Gainers
Via
Benzinga
Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session
August 17, 2022
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 79.5% to $4.57 after the company announced it plans to explore the potential development of a novel monkeypox vaccine using its norovirus...
Via
Benzinga
8 Analysts Have This to Say About Arvinas
August 08, 2022
Over the past 3 months, 8 analysts have published their opinion on Arvinas (NASDAQ:ARVN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Do You Have Biotech FOMO? It Might Be Time To Pay Attention To These Names
July 06, 2022
Biotech stocks continued going gangbusters Wednesday. Here's why, experts say.
Via
Investor's Business Daily
Do You Have Biotech FOMO? Why Cogent, Arvinas And Others Are Flying
July 06, 2022
Biotech stocks continued going gangbusters Wednesday. Here's why, experts say.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2022
June 21, 2022
Upgrades
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2022
May 09, 2022
Upgrades
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.